Stock CPHI CHINA PHARMA HOLDINGS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Financials China Pharma Holdings, Inc.

Equities

CPHI

US16941T3023

Pharmaceuticals

Delayed Nyse
Other stock markets
 19:18:08 14/05/2024 BST 		5-day change 1st Jan Change
0.33 USD +2.26% Intraday chart for China Pharma Holdings, Inc. +4.76% -45.45%
04-01 China Pharma Holdings, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
02-23 China Pharma to Conduct 1-For-5 Reverse Stock Split; Shares Fall After-Hours MT

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 11.22 10.32 19.43 22.85 4.953 3.987
Enterprise Value (EV) 1 19.2 15.84 25.9 30.48 11.68 7.197
P/E ratio -1.04 x -0.5 x -6.78 x -6.55 x -1.27 x -0.66 x
Yield - - - - - -
Capitalization / Revenue 0.91 x 0.94 x 1.79 x 2.37 x 0.61 x 0.57 x
EV / Revenue 1.56 x 1.45 x 2.38 x 3.16 x 1.44 x 1.03 x
EV / EBITDA -27.1 x -34.1 x 256 x 134 x -13.8 x 3,927 x
EV / FCF 5.44 x 4.03 x -44.2 x -47.5 x 13.7 x -42.7 x
FCF Yield 18.4% 24.8% -2.26% -2.11% 7.28% -2.34%
Price to Book 0.37 x 1.12 x 2.54 x 3.8 x 1.67 x 0.86 x
Nbr of stocks (in thousands) 872 872 872 947 1,033 6,590
Reference price 2 12.87 11.84 22.29 24.13 4.795 0.6050
Announcement Date 28/03/19 30/03/20 26/03/21 30/03/22 30/03/23 01/04/24
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 12.33 10.92 10.87 9.642 8.104 7.011
EBITDA 1 -0.7096 -0.4639 0.1012 0.2273 -0.8484 0.001833
EBIT 1 -3.968 -3.393 -2.578 -2.861 -3.549 -2.752
Operating Margin -32.18% -31.06% -23.73% -29.67% -43.79% -39.25%
Earnings before Tax (EBT) 1 -10.86 -20.7 -2.867 -3.399 -3.973 -3.079
Net income 1 -10.75 -20.7 -2.867 -3.399 -3.973 -3.079
Net margin -87.18% -189.51% -26.38% -35.26% -49.02% -43.91%
EPS 2 -12.33 -23.75 -3.286 -3.685 -3.779 -0.9099
Free Cash Flow 1 3.529 3.934 -0.5854 -0.6422 0.8497 -0.1686
FCF margin 28.62% 36.01% -5.39% -6.66% 10.49% -2.4%
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 28/03/19 30/03/20 26/03/21 30/03/22 30/03/23 01/04/24
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 7.99 5.52 6.47 7.63 6.73 3.21
Net Cash position 1 - - - - - -
Leverage (Debt/EBITDA) -11.25 x -11.9 x 63.95 x 33.56 x -7.929 x 1,751 x
Free Cash Flow 1 3.53 3.93 -0.59 -0.64 0.85 -0.17
ROE (net income / shareholders' equity) -29.3% -105% -33.3% -48.5% -77.1% -52.4%
ROA (Net income/ Total Assets) -4.71% -6.27% -7.43% -8.17% -11% -10%
Assets 1 228.3 330.1 38.56 41.61 36.21 30.66
Book Value Per Share 2 34.60 10.60 8.780 6.360 2.860 0.7000
Cash Flow per Share 2 1.360 1.230 1.050 5.130 1.350 0.1300
Capex 1 0.05 0.14 0.87 0.44 0.4 0.01
Capex / Sales 0.41% 1.24% 7.98% 4.54% 4.96% 0.16%
Announcement Date 28/03/19 30/03/20 26/03/21 30/03/22 30/03/23 01/04/24
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Other Pharmaceuticals

1st Jan change Capi.
CHINA PHARMA HOLDINGS, INC. Stock China Pharma Holdings, Inc.
-45.45% 4.78M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+30.75% 682B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+30.35% 586B
JOHNSON & JOHNSON Stock Johnson & Johnson
-3.57% 364B
MERCK & CO., INC. Stock Merck & Co., Inc.
+18.02% 327B
ABBVIE INC. Stock AbbVie Inc.
+3.74% 285B
ASTRAZENECA PLC Stock AstraZeneca PLC
+15.53% 240B
NOVARTIS AG Stock Novartis AG
+10.16% 209B
ROCHE HOLDING AG Stock Roche Holding AG
-8.14% 203B
AMGEN INC. Stock Amgen Inc.
+7.91% 165B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. CPHI Stock
  4. Financials China Pharma Holdings, Inc.